COVID-19 and the clinical hematology laboratory.
Identifieur interne : 000000 ( PubMed/Corpus ); suivant : 000001COVID-19 and the clinical hematology laboratory.
Auteurs : John L. Frater ; Gina Zini ; Giuseppe D'Onofrio ; Heesun J. RogersSource :
- International journal of laboratory hematology [ 1751-553X ] ; 2020.
Abstract
The ongoing COVID-19 pandemic originated in Wuhan, Hubei Province, China in December 2019. The etiologic agent is a novel coronavirus of presumed zoonotic origin with structural similarity to the viruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Like SARS and MERS, COVID-19 infection manifests most frequently with lower respiratory symptoms. A minority of patients progress to acute respiratory distress syndrome/ diffuse alveolar damage. In addition to its central role in the diagnosis of COVID-19 infection, the clinical laboratory provides critical information to clinicians regarding prognosis, disease course, and response to therapy. The purpose of this review is to 1) provide background context about the origins and course of the pandemic 2) discuss the laboratory's role in the diagnosis of COVID-19 infection 3) summarize the current state of biomarker analysis in COVID-19 infection, with an emphasis on markers derived from the hematology laboratory 4) comment on the impact of COVID-19 on hematology laboratory safety, and 5) describe the impact the pandemic has had on organized national and international educational activities worldwide.
DOI: 10.1111/ijlh.13229
PubMed: 32311826
Links to Exploration step
pubmed:32311826Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19 and the clinical hematology laboratory.</title><author><name sortKey="Frater, John L" sort="Frater, John L" uniqKey="Frater J" first="John L" last="Frater">John L. Frater</name><affiliation><nlm:affiliation>Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Zini, Gina" sort="Zini, Gina" uniqKey="Zini G" first="Gina" last="Zini">Gina Zini</name><affiliation><nlm:affiliation>Hematology and Clinical Pathology, Catholic University of Rome, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="D Onofrio, Giuseppe" sort="D Onofrio, Giuseppe" uniqKey="D Onofrio G" first="Giuseppe" last="D'Onofrio">Giuseppe D'Onofrio</name><affiliation><nlm:affiliation>Hematology and Clinical Pathology, Catholic University of Rome, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Rogers, Heesun J" sort="Rogers, Heesun J" uniqKey="Rogers H" first="Heesun J" last="Rogers">Heesun J. Rogers</name><affiliation><nlm:affiliation>Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32311826</idno><idno type="pmid">32311826</idno><idno type="doi">10.1111/ijlh.13229</idno><idno type="wicri:Area/PubMed/Corpus">000000</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000000</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19 and the clinical hematology laboratory.</title><author><name sortKey="Frater, John L" sort="Frater, John L" uniqKey="Frater J" first="John L" last="Frater">John L. Frater</name><affiliation><nlm:affiliation>Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Zini, Gina" sort="Zini, Gina" uniqKey="Zini G" first="Gina" last="Zini">Gina Zini</name><affiliation><nlm:affiliation>Hematology and Clinical Pathology, Catholic University of Rome, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="D Onofrio, Giuseppe" sort="D Onofrio, Giuseppe" uniqKey="D Onofrio G" first="Giuseppe" last="D'Onofrio">Giuseppe D'Onofrio</name><affiliation><nlm:affiliation>Hematology and Clinical Pathology, Catholic University of Rome, Rome, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Rogers, Heesun J" sort="Rogers, Heesun J" uniqKey="Rogers H" first="Heesun J" last="Rogers">Heesun J. Rogers</name><affiliation><nlm:affiliation>Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">International journal of laboratory hematology</title><idno type="eISSN">1751-553X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The ongoing COVID-19 pandemic originated in Wuhan, Hubei Province, China in December 2019. The etiologic agent is a novel coronavirus of presumed zoonotic origin with structural similarity to the viruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Like SARS and MERS, COVID-19 infection manifests most frequently with lower respiratory symptoms. A minority of patients progress to acute respiratory distress syndrome/ diffuse alveolar damage. In addition to its central role in the diagnosis of COVID-19 infection, the clinical laboratory provides critical information to clinicians regarding prognosis, disease course, and response to therapy. The purpose of this review is to 1) provide background context about the origins and course of the pandemic 2) discuss the laboratory's role in the diagnosis of COVID-19 infection 3) summarize the current state of biomarker analysis in COVID-19 infection, with an emphasis on markers derived from the hematology laboratory 4) comment on the impact of COVID-19 on hematology laboratory safety, and 5) describe the impact the pandemic has had on organized national and international educational activities worldwide.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32311826</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1751-553X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>International journal of laboratory hematology</Title><ISOAbbreviation>Int J Lab Hematol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and the clinical hematology laboratory.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/ijlh.13229</ELocationID><Abstract><AbstractText>The ongoing COVID-19 pandemic originated in Wuhan, Hubei Province, China in December 2019. The etiologic agent is a novel coronavirus of presumed zoonotic origin with structural similarity to the viruses responsible for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Like SARS and MERS, COVID-19 infection manifests most frequently with lower respiratory symptoms. A minority of patients progress to acute respiratory distress syndrome/ diffuse alveolar damage. In addition to its central role in the diagnosis of COVID-19 infection, the clinical laboratory provides critical information to clinicians regarding prognosis, disease course, and response to therapy. The purpose of this review is to 1) provide background context about the origins and course of the pandemic 2) discuss the laboratory's role in the diagnosis of COVID-19 infection 3) summarize the current state of biomarker analysis in COVID-19 infection, with an emphasis on markers derived from the hematology laboratory 4) comment on the impact of COVID-19 on hematology laboratory safety, and 5) describe the impact the pandemic has had on organized national and international educational activities worldwide.</AbstractText><CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frater</LastName><ForeName>John L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zini</LastName><ForeName>Gina</ForeName><Initials>G</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-0782-294X</Identifier><AffiliationInfo><Affiliation>Hematology and Clinical Pathology, Catholic University of Rome, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Polyclinic Foundation IRCCS, Agostino Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>d'Onofrio</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hematology and Clinical Pathology, Catholic University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Heesun J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Lab Hematol</MedlineTA><NlmUniqueID>101300213</NlmUniqueID><ISSNLinking>1751-5521</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32311826</ArticleId><ArticleId IdType="doi">10.1111/ijlh.13229</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000000 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000000 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:32311826
|texte= COVID-19 and the clinical hematology laboratory.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32311826" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |